Literature DB >> 29956575

Immunohistochemical analysis and comparison of napsin A, TTF1, SPA and CK7 expression in primary lung adenocarcinoma.

L Jin1, Y Liu1, X Wang1, X Qi1.   

Abstract

We investigated the expression of napsin A, TTF1, SPA and CK7 in primary lung adenocarcinoma (ADC) and compared antibody specificity and sensitivity. We used immunohistochemistry (IHC) using antibodies directed against napsin A, TTF1, SPA, and CK7 on cancer tissue from 454 patients diagnosed with lung cancer. In primary lung ADC, napsin A exhibited a sensitivity of 87.25% and specificity of 95.02%, TTF1 exhibited a sensitivity of 80.72% and specificity of 90.48%, SPA exhibited a sensitivity of 60.46% and specificity of 94.87% and CK7 exhibited a sensitivity of 100% and specificity of 80.31%. The order of sensitivity of the four indicators was CK7 > napsin A > TTF1 > SPA, and the order of specificity was napsin A > SPA > TTF1 > CK7. We can select effective indicators for diagnostic and differential diagnostic purposes based on differences in sensitivity and specificity.

Entities:  

Keywords:  adenocarcinoma; cytokeratin 7; immunohistochemistry; lung; marker; napsin A; pulmonary surfactant-associated protein A; thyroid transcription factor 1

Mesh:

Substances:

Year:  2018        PMID: 29956575     DOI: 10.1080/10520295.2018.1444790

Source DB:  PubMed          Journal:  Biotech Histochem        ISSN: 1052-0295            Impact factor:   1.718


  5 in total

1.  The E3 ubiquitin ligase HECW1 targets thyroid transcription factor 1 (TTF1/NKX2.1) for its degradation in the ubiquitin-proteasome system.

Authors:  Jia Liu; Su Dong; Lian Li; Heather Wang; Jing Zhao; Yutong Zhao
Journal:  Cell Signal       Date:  2019-03-05       Impact factor: 4.315

2.  Epithelial cell size dysregulation in human lung adenocarcinoma.

Authors:  Clifford W Sandlin; Song Gu; Jun Xu; Charuhas Deshpande; Michael D Feldman; Matthew C Good
Journal:  PLoS One       Date:  2022-10-06       Impact factor: 3.752

3.  Napsin A Expression in Subtypes of Thyroid Tumors: Comparison with Lung Adenocarcinomas.

Authors:  Jianghua Wu; Yanhui Zhang; Tingting Ding; Runfen Cheng; Wenchen Gong; Yuhong Guo; Ye Luo; Yi Pan; Qiongli Zhai; Wei Sun; Dongmei Lin; Baocun Sun
Journal:  Endocr Pathol       Date:  2020-03       Impact factor: 3.943

4.  Almonertinib-induced interstitial lung disease: A case report.

Authors:  Ting Jiang; Yiyang Luo; Binbin Wang
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

5.  Napsin A Expression in Human Tumors and Normal Tissues.

Authors:  Sören Weidemann; Jan Lukas Böhle; Hendrina Contreras; Andreas M Luebke; Martina Kluth; Franziska Büscheck; Claudia Hube-Magg; Doris Höflmayer; Katharina Möller; Christoph Fraune; Christian Bernreuther; Michael Rink; Ronald Simon; Anne Menz; Andrea Hinsch; Patrick Lebok; Till Clauditz; Guido Sauter; Ria Uhlig; Waldemar Wilczak; Stefan Steurer; Eike Burandt; Rainer Krech; David Dum; Till Krech; Andreas Marx; Sarah Minner
Journal:  Pathol Oncol Res       Date:  2021-04-20       Impact factor: 3.201

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.